Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Electrolyzed calcium for behavioral and psychological symptoms in Alzheimer's disease
jRCTs031200068Completed
- Sponsor
- Morita Pharmaceutical
- Start
- Sep 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of calcium in Alzheimer's disease (AD), sponsored by Morita Pharmaceutical. Primary endpoint: Neuropsychiatric Inventory-Questionnaire (NPI-Q). Started Sep 2020; status: completed.
02
Drugs
calcium
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on jRCTs031200068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031200068.